Key result
Tissue-tracking mitral annular displacement (TMAD) was superior to SF, EF, and s' for detecting impaired global longitudinal strain at 48 hours (AUC 0.96; 95% CI 0.91-1.00; P<0.02).
Why the study?
The feasibility, accuracy, and reproducibility of tissue-tracking mitral annular displacement compared with other measures of LV systolic function in healthy preterm and term neonates were unknown.
Does tissue-tracking mitral annular displacement (TMAD) accurately detect impaired global longitudinal strain compared to other measures of LV systolic function in healthy preterm and term neonates?
Observational
Does tissue-tracking mitral annular displacement (TMAD) accurately detect impaired global longitudinal strain compared to other measures of LV systolic function in healthy preterm and term neonates?
Tissue-tracking mitral annular displacement is a feasible, accurate, and reproducible echocardiographic measure of left ventricular systolic function in neonates during the first 48 hours of life.
OBJECTIVES: To assess the feasibility, accuracy, and reproducibility of tissue-tracking mitral annular displacement (TMAD) compared with other measures of left ventricular systolic function in healthy preterm and term neonates in the transitional period. METHODS: This was a prospective observational study. Two echocardiograms were performed at 24 and 48 hours of life. TMAD, shortening fraction (SF), ejection fraction (EF), s', and global longitudinal strain (GLS) were measured offline. Accuracy to detect impaired GLS was tested by ROC curve analysis. DeLong test was used to compare AUCs. Intra and interobserver reproducibility of the off-line analysis was calculated. RESULTS: Mean ± SD gestational age and weight were 34.2 ± 3.8 weeks and 2162 ± 833 g, respectively. TMAD was feasible in 168/180 scans (93%). At 24 hours the AUC (95% CI) of SF, EF, s', and TMAD (%) was 0.51 (0.36-0.67), 0.68 (0.54-0.82), 0.63 (0.49-0.77), and 0.89 (0.79-0.99) respectively. At 48 hours the AUC (95% CI) of SF, EF, s', and TMAD (%) was 0.64 (0.51-0.77), 0.59 (0.37-0.80), 0.70 (0.54-0.86), and 0.96 (0.91-1.00), respectively. The AUC of TMAD was superior to the AUC of SF, EF, s', at both timepoints (P < .02). Intraclass correlation coefficients (95% CI) of intra and interobserver reproducibility of TMAD were 0.97 (0.95-0.99) and 0.94 (0.88-0.97), respectively. CONCLUSION: TMAD showed improved accuracy and optimal reproducibility in neonates in the first 48 hours of life.
No takes yet. Share an insight, caveat, or question.
Ficial et al. (2023) conducted an observational in Healthy preterm and term neonates. Tissue-tracking mitral annular displacement (TMAD) vs. Shortening fraction (SF), ejection fraction (EF), and s' was evaluated on Accuracy to detect impaired global longitudinal strain (GLS) (AUC 0.96 at 48h, 95% CI 0.91-1.00, p=< .02). Tissue-tracking mitral annular displacement (TMAD) was superior to SF, EF, and s' for detecting impaired global longitudinal strain at 48 hours (AUC 0.96; 95% CI 0.91-1.00; P<0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: